You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Endocrine Surgery
 •Prognosis/ Outcomes
 •Oncology, Other
 •Alert me on articles by topic

What Prognostic Factors Are Important in Duodenal Adenocarcinoma?

Faisal G. Bakaeen, MA, MB, BCh; Michel M. Murr, MD; Michael G. Sarr, MD; Geoffrey B. Thompson, MD; Michael B. Farnell, MD; David M. Nagorney, MD; David R. Farley, MD; Jon A. van Heerden, MD; Lisa M. Wiersema, MD; Cathy D. Schleck, BS; John H. Donohue, MD

Arch Surg. 2000;135:635-642.

Hypothesis  Survival of patients with adenocarcinoma of the duodenum depends on the ability to perform a complete resection and the tumor stage

Design  Retrospective case series.

Setting  Tertiary care referral center.

Patients  A cohort of 101 consecutive patients (mean age, 62 years), undergoing surgery for duodenal adenocarcinoma from January 1, 1976, through December 31, 1996. Patients with ampullary carcinoma were specifically excluded. Mean duration of follow-up was 4 years.

Interventions  Surgery was curative in 68 patients (67%) and palliative in 33 patients (33%). Of the curative group, 50 patients (74%) underwent radical surgery, ie, 30 (60%), pancreaticoduodenectomy; 15 (30%), pylorus-preserving pancreaticoduodenectomy; and 5 (10%), total pancreatectomy. A more limited resection procedure was used in 18 patients (26%) involving a segmental duodenal resection in 15 (83%) and a transduodenal excision in 3 (17%).

Main Outcomes and Measures  Tumor recurrence, patient survival, and correlation with patient and tumor variables using univariate and multivariate analysis.

Results  Actuarial 5-year survival for the curative group was 54%. Only 1 patient in the unresected group survived beyond 3 years. Nodal metastasis (P=.002), advanced tumor stage (P<.001), positive resection margin (P=.02), and weight loss (P<.001) had a significant negative impact on survival in multivariate analysis. Tumor grade, size, and location within the duodenum had no impact on survival. Patient age and tumor depth of invasion influenced survival in univariate analysis, but lost their prognostic significance in multivariate analysis.

Conclusions  Metastasis to lymph nodes, advanced tumor stage, and positive resection margins are associated with decreased survival in patients with duodenal adenocarcinoma. An aggressive surgical approach that achieves complete tumor resection with negative margins should be pursued. Pancreaticoduodenectomy is usually required for cancers of the first and second portion of the duodenum. Segmental resection may be appropriate for selected patients, especially for tumors of the distal duodenum.


From the Departments of Surgery (Drs Bakaeen, Murr, Sarr, Thompson, Farnell, Nagorney, Farley, van Heerden, and Donohue), Pathology (Dr Wiersema), and Biostatistics (Ms Schleck), Mayo Clinic and Mayo Foundation, Rochester, Minn.


RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(6):744-745.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma.
Gold et al.
Ann. Surg. Oncol. 2007;14:3159-3167.
ABSTRACT | FULL TEXT  

Surgical Management and Outcome in Primary Adenocarcinoma of the Small Bowel
Agrawal et al.
Ann. Surg. Oncol. 2007;14:2263-2269.
ABSTRACT | FULL TEXT  

Cyclooxygenase-2 Overexpression Is Associated with a Poor Outcome in Resected Ampullary Cancer Patients
Santini et al.
Clin. Cancer Res. 2005;11:3784-3789.
ABSTRACT | FULL TEXT  

Periampullary Tumors: High-Spatial-Resolution MR Imaging and Histopathologic Findings in Ampullary Region Specimens
Sugita et al.
Radiology 2004;231:767-774.
ABSTRACT | FULL TEXT  

Editorial: Duodenal Adenocarcinoma: Is Total Lymph Node Sampling Predictive of Outcome?
Gibbs
Ann. Surg. Oncol. 2004;11:354-355.
FULL TEXT  

Adenocarcinoma of the Duodenum: Importance of Accurate Lymph Node Staging and Similarity in Outcome to Gastric Cancer
Sarela et al.
Ann. Surg. Oncol. 2004;11:380-386.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.